Bone Morphogenetic Protein 4 Expressed in Esophagitis Induces a Columnar Phenotype in Esophageal Squamous Cells

Gastroenterology

Volumn 132, Issue 7, 2007, Pages 2412-2421

  Milano, Francesca ^a   van Baal, Jantine W P M ^a   Buttar, Navtej S ^b   Rygiel, Agnieszka M ^a   de Kort, Floor ^a   DeMars, Cathrine J ^b   Rosmolen, Wilda D ^a   Bergman, Jacques J G H M ^a   van Marle, Jan ^a   Wang, Kenneth K ^b   Peppelenbosch, Maikel P ^c   Krishnadath, Kausilia K ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CYTOKERATIN; NOGGIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARRETT ESOPHAGUS; CELL TRANSFORMATION; COLUMNAR EPITHELIUM; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SQUAMOUS CELL; UPREGULATION; WESTERN BLOTTING;

EID: 34249982283     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.03.026     Document Type: Article

References (28)

1. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
2. Shaheen N.J. Advances in Barrett esophagus and esophageal adenocarcinoma. Gastroenterology 128 (2005) 1554-1566
3. Bytzer P., Christensen P.B., Damkier P., Vinding K., and Seersholm N. Adenocarcinoma of the esophagus and Barrett esophagus: a population-based study. Am J Gastroenterol 94 (1999) 86-91
4. Ransford R.A., and Jankowski J.A. Genetic versus environmental interactions in the oesophagitis-metaplasia-dysplasia-adenocarcinoma sequence (MCS) of Barrett oesophagus. Acta Gastroenterol Belg 63 (2000) 18-21
5. Locke III G.R., Talley N.J., Fett S.L., Zinsmeister A.R., and Melton III L.J. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
6. Winters Jr. C., Spurling T.J., Chobanian S.J., Curtis D.J., Esposito R.L., Hacker III J.F., Johnson D.A., Cruess D.F., Cotelingam J.D., Gurney M.S., et al. Barrett esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92 (1987) 118-124
7. Mann N.S., Tsai M.F., and Nair P.K. Barrett esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 84 (1989) 1494-1496
8. van Baal J.W., Milano F., Rygiel A.M., Bergman J.J., Rosmolen W.D., van Deventer S.J., Wang K.K., Peppelenbosch M.P., and Krishnadath K.K. A comparative analysis by SAGE of gene expression profiles of Barrett esophagus, normal squamous esophagus, and gastric cardia. Gastroenterology 129 (2005) 1274-1281
9. Wall N.A., and Hogan B.L. TGF-beta related genes in development. Curr Opin Genet Dev 4 (1994) 517-522
10. Kingsley D.M., Bland A.E., Grubber J.M., Marker P.C., Russell L.B., Copeland N.G., and Jenkins N.A. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell 71 (1992) 399-410
11. Hollnagel A., Oehlmann V., Heymer J., Ruther U., and Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 274 (1999) 19838-19845
12. Rosendahl A., Pardali E., Speletas M., Ten Dijke P., Heldin C.H., and Sideras P. Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol 27 (2002) 160-169
13. Kaiser S., Schirmacher P., Philipp A., Protschka M., Moll I., Nicol K., and Blessing M. Induction of bone morphogenetic protein-6 in skin wounds. Delayed reepitheliazation and scar formation in BMP-6 overexpressing transgenic mice. J Invest Dermatol 111 (1998) 1145-1152
14. Frank S., Madlener M., and Werner S. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 271 (1996) 10188-10193
15. Hubner G., Hu Q., Smola H., and Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol 173 (1996) 490-498
16. Washington K., Gottfried M.R., and Telen M.J. Tissue culture of epithelium derived from Barrett oesophagus. Gut 35 (1994) 879-883
17. Palanca-Wessels M.C., Barrett M.T., Galipeau P.C., Rohrer K.L., Reid B.J., and Rabinovitch P.S. Genetic analysis of long-term Barrett esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology 114 (1998) 295-304
18. Buttar N.S., Wang K.K., Leontovich O., Westcott J.Y., Pacifico R.J., Anderson M.A., Krishnadath K.K., Lutzke L.S., and Burgart L.J. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett esophagus. Gastroenterology 122 (2002) 1101-1112
19. Buttar N.S., Wang K.K., Anderson M.A., Dierkhising R.A., Pacifico R.J., Krishnadath K.K., and Lutzke L.S. The effect of selective cyclooxygenase-2 inhibition in Barrett esophagus epithelium: an in vitro study. J Natl Cancer Inst 94 (2002) 422-429
20. Pera M., Trastek V.F., Carpenter H.A., Fernandez P.L., Cardesa A., Mohr U., and Pairolero P.C. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 55 (1993) 1386-1392 discussion 1392-1393
21. Liu W., Oh S.H., Kang Yk Y., Li G., Doan T.M., Little M., Li L., Ahn K., Crenshaw III E.B., and Frenz D.A. Bone morphogenetic protein 4 (BMP-4): a regulator of capsule chondrogenesis in the developing mouse inner ear. Dev Dyn 226 (2003) 427-438
22. Barrett M.T., Yeung K.Y., Ruzzo W.L., Hsu L., Blount P.L., Sullivan R., Zarbl H., Delrow J., Rabinovitch P.S., and Reid B.J. Transcriptional analyses of Barrett metaplasia and normal upper GI mucosae. Neoplasia 4 (2002) 121-128
23. Moll R., Franke W.W., Schiller D.L., Geiger B., and Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 (1982) 11-24
24. Moll R. Cytokeratins in the histological diagnosis of malignant tumors. Int J Biol Markers 9 (1994) 63-69
25. Quinlan R.A., Schiller D.L., Hatzfeld M., Achtstatter T., Moll R., Jorcano J.L., Magin T.M., and Franke W.W. Patterns of expression and organization of cytokeratin intermediate filaments. Ann N Y Acad Sci 455 (1985) 282-306
26. Southgate J., Harnden P., and Trejdosiewicz L.K. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications. Histol Histopathol 14 (1999) 657-664
27. Gulmann C., Shaqaqi O.A., Grace A., Leader M., Patchett S., Butler D., and Kay E. Cytokeratin 7/20 and MUC1, 2, 5AC, and 6 expression patterns in Barrett esophagus and intestinal metaplasia of the stomach: intestinal metaplasia of the cardia is related to Barrett esophagus. Appl Immunohistochem Mol Morphol 12 (2004) 142-147
28. Ormsby A.H., Goldblum J.R., Rice T.W., Richter J.E., Falk G.W., Vaezi M.F., and Gramlich T.L. Cytokeratin subsets can reliably distinguish Barrett esophagus from intestinal metaplasia of the stomach. Hum Pathol 30 (1999) 288-294